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Abstract
Background: White adipose tissue (WAT) is a disperse organ acting as energy storage depot and
endocrine/paracrine controlling factor in the management of energy availability and inflammation. WAT
sites response under energy-related stress is not uniform. In the present study we have analyzed how
different WAT sites respond to limited food restriction as a way to better understand the role of WAT
in the pathogenesis of the metabolic syndrome.
Methods: Overweight male rats had their food intake reduced a 40% compared with free-feeding
controls. On day ten, the rats were killed; circulating glucose, insulin, leptin, adiponectin, triacylglycerols
and other parameters were measured. The main WAT sites were dissected: mesenteric, retroperitoneal,
epididymal and subcutaneous inguinal, which were weighed and frozen. Later all subcutaneous WAT was
also dissected and weighed. Samples were used for DNA (cellularity) analysis and mRNA extraction and
semiquantitarive RT-PCR analysis of specific cytokine gene expressions.
Results: There was a good correlation between serum leptin and cumulative WAT leptin gene mRNA,
but not for adiponectin. Food restriction reduced WAT size, but not its DNA content (except for
epididymal WAT). Most cytokines were correlated to WAT site weight, but not to DNA. There was WAT
site specialization in the differential expression (and probably secretion) of adipokines: subcutaneous WAT
showed the highest concentration for leptin, CD68 and MCP-1, mesenteric WAT for TNFα (and both
tissues for the interleukins 1β and 6); resistin was highly expressed in subcutaneous and retroperitoneal
WAT.
Conclusion: Food restriction induced different patterns for mesenteric and the other WAT sites, which
may be directly related to both the response to intestine-derived energy availability, and an inflammatory-
related response. However, retroperitoneal WAT, and to a lower extent, subcutaneous and epididymal,
reacted decreasing the expression of inflammatory markers and the signaling of decreased energy
availability in their stores. The varying cytokine expression patterns highlight the fact that WAT sites show
different inflammatory and signaling responses to energy availability; they are too much different to simply
extend to the whole-body WAT the findings of one or even a couple of sites.
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Background
White adipose tissue (WAT) is currently considered a
fairly dynamic tissue, which behaves largely as a disperse
"organ" [1] with critical energy-handling regulatory,
endocrine and paracrine function [2] in addition to its
classical lipid storage activity. In the latter role, WAT is
considered to be the main repository for fat reserves, in
spite of the fact that carefully dissected WAT mass [3] at
most justifies about half the body lipid of a normal-
weight rat. Muscle contains a sizeable amount of intramy-
ocellular fat [4]; muscle fat also includes significant
masses of adipose tissue, infiltrated between and around
muscular structures [5]. However, most studies of WAT
have been centered on the main WAT macroscopic
masses, which are generally assumed to be the main sites
of functionality of the adipose organ.
Different WAT sites are known to possess different cell
sizes [6], ability to react to hormonal and pharmacologi-
cal stimuli [7] and proliferative responses [8]. The classi-
cal distinction between visceral and subcutaneous or
peripheral WAT is closely related to the development/
maintenance of the metabolic syndrome [9] and is justi-
fied by different metabolic behavior (e.g. the handling of
excess lipid) [10]. The implication of immune responsive-
ness and cytokine secretion have been found to be widely
different depending on the WAT site studied [11], which
severely limits the actual significance of the conclusions
derived from the analysis of data from a single WAT site.
The role of WAT as a regulatory organ, both in the
response to challenges to energy homeostasis and the
closely-related inflammatory response. have been widely
studied [12]. The relevance of non-adipocyte cells in WAT,
such as lymphocytes [13], macrophages [14,15], endothe-
lial/vascular or stromatal cells [16] and even nervous ter-
minations [17], may justify in part the different pattern of
secretion of apocrine or paracrine signals. The relative
presence of non-adipocyte cells is again a factor of site dif-
ferentiation, since macrophage penetration [18,19],
eNOS activity [20] and leptin secretion [21], to cite only a
few factors, are site-related. In fact, the protein signals
(adipokines and hormones) secreted by WAT are of a
widely different nature, and play a large number of differ-
ent paracrine and endocrine functions [22], affecting the
function of vessels, muscle, liver, brain and other organs
and systems. This function is closely related to situations
of WAT distress, such as obesity [11] and other metabolic
syndrome alterations such as insulin resistance and hyper-
tension [23]. WAT response, i.e. secreting short- or
medium-term signals, helps modulate (orchestrate?) a
concerted response by the whole organism to energy
homeostasis challenges.
In the present study we intended to further delve in WAT
site-related differences in adipokine signal response
induced by a relatively mild (i.e. within the physiological
range) metabolic stress: reduced energy availability. The
expected responses to a 40% reduction in food intake (a
situation comparable to common human dieting sched-
ules but applied to a rodent, which has a higher metabolic
rate) should be in line with a reduction of WAT energy
content and its emission of energy-preservative signals. As
basic model we used male overweight rats [24], which
contain sufficient fat to make visible its loss in the short
term without the problems posed by the metabolic alter-
ations of a fully settled obesity.
Methods
Animals and sample preparation
Adult male Wistar rats were made overweight by a limited
period (30 days) of cafeteria diet feeding, as previously
described [24]. The rats, initially weighing 350 ± 5 g, were
kept under standard conditions of housing and feeding
[24].
The animals were kept, handled and killed following the
specific procedures approved by the University of Barce-
lona Animal Welfare and Ethics Committee, in full con-
formity with the norms and proceedings set forth by the
European Union and the Governments of Spain and Cata-
lonia.
Two groups of six rats each were randomly selected: con-
trols and "food-restricted" (FR). The controls had free
access to pellet food (maintenance chow, Panlab, Barce-
lona, Spain). A previous experiment showed that over-
weight male rats of this size/age ate a mean 18.0 g/d (i.e.
257 kJ/d) of the same rat chow. Since food reduction was
set at 40% of the basic diet, FR rats were allowed only 10.8
g per day and rat (i.e. 154 kJ). All rats had water available
ad libitum. During the experiment, all FR rats ate all the
food supplied every day.
On day 10, the rats were killed by decapitation. Blood was
allowed to clot, and the serum was stored frozen at -80°C
until processed. The following WAT pads were rapidly iso-
lated and completely dissected: intestine-related
mesenteric WAT, perigonadal (epididymal), retroperito-
neal cordons, and the subcutaneous inguinal fat pads. The
samples were blotted and carefully cleaned of extraneous
material (epididymis, pancreas, dermis), weighed, frozen
in liquid nitrogen and kept at -80°C; this was done in the
shortest time possible. The rest of subcutaneous WAT was
later dissected and weighed. The dispersion of subcutane-
ous WAT and the need to excise and process rapidly tissue
samples brought us to the compromise of analyzing the
well defined inguinal cordons and extend the results to
the whole subcutaneous WAT, which complete dissection
took more than 25 min per rat. We are aware of this
potential source of error, since there are no data availableCardiovascular Diabetology 2009, 8:42 http://www.cardiab.com/content/8/1/42
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about the metabolic uniformity of different locations of
subcutaneous WAT.
Blood serum was used for the measurement of glucose
(Trinder kit, Sigma, St. Louis, MO, USA) and non-esteri-
fied fatty acids (NEFA kit, Wako Chemicals, Neuss, Ger-
many) by enzymatic-colorimetric methods; total
triacylglycerols by a lipase-glycerol kinase spectrophoto-
metric method (kit 11528, Biosystems, Barcelona, Spain);
and total cholesterol (both in serum and liver samples) by
an enzymatic-colorimetric method (Cholesterol reagent
easy, Menarini, Firenze, Italy). Serum samples were also
used for the radioimmunoanalysis measurements of lep-
tin (kit RL-83K, Linco, St Charles, MO USA), adiponectin
(kit MADP-60HK, Linco), and insulin (kit SRI-13K,
Linco).
Analysis of gene expression
Total WAT tissue RNA was extracted using the Tripure rea-
gent (Roche Applied Science, Indianapolis IN USA), and
were quantified in a ND-100 spectrophotometer (Nano-
drop Technologies, Wilmington DE USA). Real-time PCR
(RT-PCR) amplification was carried out using 0.010 mL
amplification mixtures containing Power SYBR Green
PCR Master Mix (Applied Biosystems, Foster City, CA
USA), equivalent to 8 ng of reverse-transcribed RNA and
300 nM primers. Reactions were run on an ABI PRISM
7900 HT detection system (Applied Biosystems).
Gene expression of perilipin, as well as leptin, adiponec-
tin, interleukin 1β, interleukin 6, TNFα, resistin, visfatin,
PAI-1, VEGF-A, MCP1, and the macrophage marker CD68
were estimated using a semiquantitative approach for the
ultimate estimation of the number of copies of each
expressed gene mRNAs per unit of tissue weight as previ-
ously described [25]. In any case, cyclophilin was used as
charge control gene in all samples. The list of primers used
is given in Table 1.
The data were expressed as the absolute amount of the
mRNAs corresponding to the given gene in the whole
mass of the WAT pad as a way to render comparable the
ability to express the gene regardless of cell size (i.e. fat
content), but nevertheless considering its physiological
significance as an organ. In the case of subcutaneous adi-
pose tissue, the data obtained for the inguinal cordons
were applied to the whole tissue mass dissected. Since the
four WAT sites selected represent a large majority of the
rat's total WAT [3], we assumed that, in the whole, they
constituted a fairly representative estimation of that total
'independent' WAT mass, i.e. not associated to other
organs (muscle) or structures (vessels).
Table 1: Primers used for semiquantitative estimation of gene expression
gene acronym forward (5' > 3') reverse (3' > 5') bp
cyclophilin A Ppia CTGAGCACTGGGGAGAAAGGA GAAGTCACCACCCTGGCACA 87
perilipin Plin GAGGGGCTGATCTGGCTTTG GCATCTTTTGCCGTCCTGAA 102
leptin Lep CGGTTCCTGTGGCTTTGGT CCGACTGCGTGTGTGAAATG 130
adiponectin Adipoq GGAGACGCAGGTGTTCTTGG AGCCCTACGCTGAATGCTGA 152
resistin Retn TCATGCCCAGAACCGAGTTG CAGCCCCAGGACAAGGAAGA 109
tumor necrosis factor Tnf GGCTCCCTCTCATCAGTTCCA CGCTTGGTGGTTTGCTACGA 104
visfatin Pbef1 TCTGGAAATCCGCTCGACAC CACTCCGTCCCCTTGAATGA 129
CD68 Cd68 CCATCCCCACTTGGCTCTCT TGCGCTGAGAATGTCCACTG 156
MCP1 Cc12 TGCAGGTCTCTGTCACGCTTC TTCTCCAGCCGACTCATTGG 148
interleukin 1β Il1b ATGCCTCGTGCTGTCTGACC GGCCACAGGGATTTTGTCG 130
interleukin 6 Il6 TGCCTTCTTGGGACTGATGTTG TGGTCTGTTGTGGGTGGTATCC 97
VEGF-A Vegfa CGTCCTGTGTGCCCCTAATG TGTGCTGGCTTTGGTGAGGT 124
PAI-1 Serpine1 CAGCACACAGCCAACCACAG GAAGCGAACCCTTTCCCAAA 143Cardiovascular Diabetology 2009, 8:42 http://www.cardiab.com/content/8/1/42
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Statistical comparison between groups and correlations
were established by using the unpaired Student's t and lin-
ear regression analysis programs of the Prism-5 package
(Graphpad Software, La Jolla CA USA). In the linear
regression analysis experiments, comparisons of paired
parameters were done for each WAT site, including in the
analysis all the animals from both dietary groups as one,
as a way to determine-using food restriction as metabolic
stimulus- the existence of coordinated changes in expres-
sions and metabolite levels.
Results
In the 10-day period studied, controls increased their
body weight 2.6 ± 0.4%, whilst the FR rats lost 8.5 ± 0.7%,
the differences being statistically significant. Figure 1
shows the weights of WAT sites and the effect of food
restriction: total weight of the four WAT sites was reduced
by 43% (P < 0.05), but their combined DNA content lost
only about 10% (not significant). Figure 1 also shows the
sum of perilipin fmols of their corresponding mRNAs in
the four WAT sites. Perilipin gene expression decreased in
a proportion similar to WAT weight; however, retroperito-
neal WAT loss in FR of fat vacuole-lining protein with
respect to controls was more marked, in contrast with the
more generalized loss of site WAT weight.
Table 2 presents the serum parameters for both groups of
rats. Glucose, triacylglycerols, insulin and leptin levels sig-
nificantly decreased with food restriction, non-esterified
fatty acids increased, and there were no changes for cho-
lesterol and adiponectin.
In Figure 2, the sum of specific mRNAs for leptin and adi-
ponectin content in the WAT sites are presented in com-
parison with the serum levels of both adipocytokines.
Overall, leptin expression in FR was reduced to a 26% of
controls, with serum leptin showing a close 21%, the dif-
ferences being significant in both cases. The correspond-
ing data for adiponectin were 69% (expression) and 97%
(levels), neither being statistically significant. In the case
of adiponectin, the only significant decrease in gene
expression was observed in retroperitoneal WAT. There
was a significant (P = 0.0003) correlation between com-
bined WAT leptin gene expression and the corresponding
serum levels when considering all the data (controls and
FR) together; this correlation was not significant (P =
0.494) in the case of adiponectin.
Effect of 10 days of 40% food restriction on WAT site weight, DNA content, and the expression of perilipin gene Figure 1
Effect of 10 days of 40% food restriction on WAT site weight, DNA content, and the expression of perilipin 
gene. The data correspond to the mean ± sem of six different animals. Gene expression data are presented as fmols of the 
corresponding mRNAs in the whole WAT site. C = controls fed ad libitum; FR = food restricted. Statistical significance of the 
differences between data groups. A star indicates an overall (i.e. combined WAT sites) significant (P < 0.05) difference between 
FR and C. A black dot indicates a significant difference in mass/gene expression for a given WAT site between FR and C.
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Figure 3 shows the effect of food restriction on the expres-
sion of a number of peptide WAT signals. In all cases, food
restriction generated a decrease in the overall specific
mRNA content of combined WAT sites that was signifi-
cant only for VEGF-A and MCP1. There were generalized
decreases for all genes tested in retroperitoneal WAT (sig-
nificant for interleukin 6, TNFα, PAI-1, resistin, visfatin,
VEGF-A, MCP1, and CD68). No significant differences
were observed for epididymal WAT. Subcutaneous WAT
showed a significant decrease in the expression of PAI-1
and VEGF-A genes. Mesenteric WAT presented a signifi-
cant increase in the expression of the visfatin gene. No sig-
nificant effects whatsoever were found for interleukin 1β.
Table 3 shows the statistical significance of the correla-
tions between specific mRNA WAT content and either
combined tissue weight or tissue DNA. There was a good
correlation between cumulative specific mRNA content
and WAT weight for all parameters studied, except tissue
DNA and visfatin. Individual WAT sites showed different
degrees of correlation between gene expression and WAT
site weight, with mesenteric WAT being the site with low-
est number of correlates. Comparison of specific mRNA
content and combined (or site) DNA content resulted in a
much lower degree of correlation: the only significant val-
ues were found for epididymal WAT, that showed a signif-
icant correlation with all parameters except for visfatin
and interleukin 6. Mesenteric WAT DNA showed a signif-
icant correlation with the specific mRNAs of adiponectin,
interleukin 1β, VEGF-A, CD68 and MCP1.
Table 4 presents, likewise, the statistical significance of the
correlations between combined (i.e. the sum of all WAT
sites) specific mRNAs and the serum parameters presented
in Table 1. There were no significant correlations for cho-
lesterol, non-esterified fatty acids and adiponectin. How-
ever, triacylglycerols, glucose, insulin and leptin were
correlated with combined WAT weight, perilipin, leptin,
VEGF-A and MCP1. Triacylglycerols were also correlated
with the expression of visfatin, adiponectin and CD68.
Insulin and leptin were also correlated with resistin, inter-
leukin 1β and PAI-1.
Discussion
The four WAT sites analyzed constitute a large proportion
of the total rat's large anatomically distinguishable WAT
[3], and its function may be somewhat different from the
ancillary role of adipocytes interspersed between other
cell types in a number of organs or tissues, such as muscle
[5]. WAT role as energy depot, energy availability control-
ler and immune response site [12,22] is commonly attrib-
Table 2: Serum parameters of overweight male rats subjected to 
10 days of reduced food intake.
parameter units control FR
glucose mM 8.01 ± 0.09 6.02 ± 0.15 *
triacylglycerols mM 1.58 ± 0.13 0.62 ± 0.05 *
non-esterified fatty acids mM 0.35 ± 0.03 0.50 ± 0.07 *
total cholesterol mM 1.36 ± 0.03 1.46 ± 0.11
insulin pM 574 ± 79 71 ± 10 *
leptin pM 47.1 ± 1.90 7.1 ± 0.7 *
adiponectin nM 80.1 ± 5.1 78.1 ± 6.1
The data are the mean ± sem of six different animals. All units are 
expressed as mmol/L. Differences between groups: * = P < 0.05 
versus controls
Effect of 10 days of 40% food restriction on WAT site leptin  and adiponectin serum levels and gene expressions Figure 2
Effect of 10 days of 40% food restriction on WAT site 
leptin and adiponectin serum levels and gene expres-
sions. The data correspond to the mean ± sem of six differ-
ent animals. The symbols used are the same as in Figure 1. 
Gene expression data are presented as fmols of the corre-
sponding mRNAs in the whole WAT site. C = controls fed 
ad libitum; FR = food restricted. Statistical significance of the 
differences between data groups. A star indicates an overall 
(i.e. combined WAT sites) significant (P < 0.05) difference 
between FR and C. A black dot indicates a significant differ-
ence in mass/gene expression for a given WAT site between 
FR and C.
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Effect of 10 days of 40% food restriction on WAT site gene expression of peptide signaling agents Figure 3
Effect of 10 days of 40% food restriction on WAT site gene expression of peptide signaling agents. The data cor-
respond to the mean ± sem of six different animals. The symbols used are the same as in Figure 1. Gene expression data are 
presented as femtomols or attomols of the corresponding mRNAs in the whole WAT site. C = controls fed ad libitum; FR = 
food restricted. Statistical significance of the differences between data groups. A star indicates an overall (i.e. combined WAT 
sites) significant (P < 0.05) difference between FR and C. A black dot indicates a significant difference in gene expression for a 
given WAT site between FR and C.
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Table 3: Statistical significance of the correlations between combined four-site WAT specific mRNA content for peptidic signaling 
agents and total four-site WAT weight or DNA content (r2 and P values)
adipokine gene expression total site mRNA copies versus weight total site mRNA copies versus DNA
RP Epi SC Me Total RP Epi SC Mes Total
site total DNA r2 0.364 0.929 NS 0.686 NS
P 0.0492 0.0001 0.0016
perilipin r2 0.594 0.766 0.563 NS 0.826 NS 0.824 NS NS NS
P 0.0091 0.0004 0.0078 0.0001 0.0001
visfatin r2 NS NS NS NS NS NS NS NS NS NS
P
leptin r2 0.507 0.745 0.656 0.647 0.882 NS 0.809 NS NS NS
P 0.0139 0.0004 0.0025 0.0028 0.0000 0.0002
resistin r2 NS 0.417 0.579 0.515 0.468 NS 0.808 NS NS NS
P 0.0317 0.0065 0.0013 0.0203 0.0004
adiponectin r2 NS 0.610 0.557 NS 0.649 NS 0.706 NS 0.429 NS
P 0.0045 0.0083 0.0027 0.0012 0.0286
TNFα r2 0.486 0.628 0.618 NS 0.523 NS 0.668 NS NS NS
P 0.0171 0.0036 0.0041 0.0119 0.0021
interleukin 1β r2 NS 0.386 0.369 NS 0.861 NS 0.403 NS 0.415 NS
P 0.0413 0.0475 0.0001 0.0358 0.0325
interleukin 6 r2 0.487 NS NS NS 0.584 NS NS NS NS NS
P 0.0168 0.0062
VEGF-A r2 0.523 0.666 0.666 0.609 0.831 NS 0.835 NS 0.529 NS
P 0.0119 0.0022 0.0021 0.0046 0.0000 0.0000 0.0111
PAI-1 r2 0.654 NS 0.805 NS 0.567 NS 0.533 NS NS NS
P 0.0026 0.0004 0.0075 0.0107
CD68 r2 0.606 0.511 0.476 0.590 0.704 NS 0.499 NS 0.533 NS
P 0.0048 0.0134 0.0187 0.0165 0.0012 0.0151 0.0107
MCP1 r2 0.488 0.746 0.476 0.455 0.781 NS 0.739 NS 0.576 NS
P 0.0167 0.0006 0.0187 0.0228 0.0003 0.0007 0.0067
The data are the mean ± sem of six different animals. All units are expressed as mmol/L. Differences between groups: * = P < 0.05 versus controlsCardiovascular Diabetology 2009, 8:42 http://www.cardiab.com/content/8/1/42
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Table 4: Statistical significance of the correlations of the serum levels of glucose, lipids, insulin, leptin and adiponectin versus the 
combined four-site WAT specific mRNA content for peptidic signaling agents and total four-site WAT weight or perilipin expression 
(r2 and P values)
adipokine gene expression total site mRNA copies versus serum levels
cholesterol NEFA TAG glucose insulin leptin adiponectin
total WAT weight r2 NS NS 0.687 0.442 0.985 0.940 NS
P 0.0030 0.0257 0.0065 0.0016
perilipin r2 NS NS 0.391 0.436 0.777 0.835 NS
P 0.0391 0.0259 0.0390 0.0194
leptin r2 NS NS 0.543 0.488 0.934 0.969 NS
P 0.0097 0.0167 0.0020 0.0003
VEGF-A r2 NS NS 0.497 0.464 0.892 0.931 NS
P 0.0154 0.0210 0.0069 0.0023
resistin r2 NS NS NS NS 0.885 0.916 NS
P 0.0081 0.0037
adiponectin r2 NS NS 0.400 NS NS NS NS
P 0.0491
visfatin r2 NS NS 0.419 NS NS NS NS
P 0.0312
TNFα r2 NS NS NS NS NS NS NS
P
interleukin 1β r2 NS NS NS NS 0.771 0.834 NS
P 0.0424 0.0197
interleukin 6 r2 NS NS NS NS NS NS NS
P
PAI-1 r2 NS NS NS NS 0.822 0.931 NS
P 0.0233 0.0468
CD68 r2 NS NS 0.425 NS NS NS NS
P 0.0298
MCP1 r2 NS NS 0.628 0.389 0.784 0.842 NS
P 0.0036 0.0403 0.0371 0.0175
The data were calculated taking into account the sum of the four sites for all samples (i.e. from both experimental groups) as a whole. All 
correlations were positive. TAG = triacylglycerols; NEFA = non-esterified fatty acids. NS = P < 0.05.Cardiovascular Diabetology 2009, 8:42 http://www.cardiab.com/content/8/1/42
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uted to the largest macroscopic adipose tissue groupings
that constitute the adipose organ [1].
There is no direct quantitative relationship between gene
expression and actual protein synthesis and its eventual
secretion, largely because of post-transcriptional regula-
tory steps, and the control of exocytosis. However, tissue
gene expression is often taken as a fairly direct indication
of the changes or trends elicited by experimental agents.
In our case, the application of a semiquantitarive proce-
dure to evaluate the amount of specific mRNAs [25,26]
allowed us to compare tissue sites differing in protein con-
tent, total mRNA, cell size and even metabolic activity
[27]. Thus, the difficulties of comparing the gene expres-
sion data in tissues losing weight due to cell size change
and/or apoptosis, can be in part circumvented by estimat-
ing the absolute amount of the corresponding mRNAs in
whole anatomically well-defined units [27]; in our case
four distinct adipose tissue sites.
Mesenteric WAT, probably the only truly visceral WAT,
contains the lower proportion of lipids, and its mean cell
size is small [27]. Subcutaneous WAT has been found to
be a higher leptin secretory site [28] with enhanced leptin
expression [29] compared with other WAT depots, a result
partly reproduced here; but subcutaneous WAT has also
small mean cell size compared with retroperitoneal, but
not perigonadal WAT [27].
Restricted feeding affects mainly the WAT lipid (energy)
content [24], and to a lower extent WAT cellularity [30]; as
a consequence, there is not a good correlation between
DNA (i.e. cell) content, perilipin expression (roughly: fat
vacuole size maintenance) and lipid (weight). The closer
relationship of some of the WAT secreted proteins to one
or other of these parameters tend to show whether they
are directly affected by energy depletion or simply the
changes observed are a consequence of diminished over-
all WAT cell content.
The only WAT site that lost DNA (albeit not significantly)
with food restriction was the epididymal, and thus is the
one for which most genes investigated show correlations
with DNA content.
Perilipin, a protein related with fat vacuole lining in
mature adipocytes [31], was closely correlated with WAT
weight, with the striking difference of mesenteric WAT,
which function is probably less related to storage of lipids
than to dietary lipid processing [27].
Total DNA content of the different WAT sites was fairly
similar, but the WAT site weights were not, resulting in
much smaller mean cell size for mesenteric WAT than for
the other sites [27]. The proportion of specific mRNAs,
however did not follow the DNA pattern nor too closely
that of weight, in a way that subcutaneous WAT share
(38% in controls) accounts for about half of adiponectin,
PAI-1, resistin or visfatin (and, perilipin, which suggests a
probable relationship between these expressions and vac-
uole size), or more than half of leptin, interleukins 1β and
6, VEGF-A, MCP1 and CD68 expression.
The comparisons of circulating leptin and adiponectin
and tissue gene expression data showed a good direct rela-
tionship between quantitative data for gene expression in
WAT and circulating leptin levels, a relationship that is
maintained in spite of the different effect of food restric-
tion on gene expression (and serum levels). This decrease
was directly related to WAT mass, as previously described
[32], but the extent of decrease was not uniform for all
sites and more marked than the loss of weight. Leptin
expression was more correlated with WAT weight (i.e.
essentially lipids) than with WAT DNA (i.e. cell numbers),
but was also well correlated with circulating energy indi-
cators such as triacylglycerols, glucose and insulin. Most
of these relationships have been already described [33],
but our results show that probably leptin (levels and
expression) is a good index to correlate the level of energy
availability, because of its direct relationship with most
serum markers.
On the other hand, circulating adiponectin (total) was not
correlated with the expression of its regulating gene, prob-
ably because active adiponectin largely depends on post-
translational molecular weight modification [34], which
is not reflected in the analytical procedure followed here.
This lack of correlation for adiponectin levels extends to
all other parameters studied, with the sole and significant
exception of triacylglycerols, in agreement with other
studies on the relationships of adiponectin and energy
availability [35]. The expression of adiponectin, however,
is well correlated with WAT weight (i.e. lipid content),
since the correlation was lost when compared with tissue
DNA (i.e. cell number) subcutaneous and retroperitoneal,
but not for epididymal and mesenteric WAT.
Under basal conditions, visfatin, a tissue-derived proxy for
some insulin functions [36], was largely expressed in the
retroperitoneal WAT. Visfatin expression was unrelated to
weight or DNA, but showed a fair correlation with circu-
lating triacylglycerols (also correlated with WAT weight),
which suggests a role for this lipid marker in the control
of visfatin.
Interleukin 6 expression was decreased in retroperitoneal
WAT, but increased (not significantly) in the mesenteric
with food restriction. These changes were unrelated to any
of the serum energy indicators studied, marking a differ-
ence with interleukin 1β, related to both insulin and lep-Cardiovascular Diabetology 2009, 8:42 http://www.cardiab.com/content/8/1/42
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tin. This suggests a more energy-related role for
interleukin 1β [37,38] than for interleukin 6, which
increase is more related to pathologic situations [39] fairly
different from the mild conditions of this restricted feed-
ing. The lack of response of TNFα expression to serum
parameters can be interpreted in this same way: a good
relationship with tissue weight (except for mesenteric
WAT) and no response to serum parameters kept well
within the non-pathological range.
Resistin has been considered a marker of insulin resist-
ance [40]; this relationship extends to leptin and WAT
weight. However its expression is only related to insulin
and leptin levels, not to serum lipid markers. The lack of
significant change in its expression under decreased
energy availability in most WAT sites hints at resistin not
playing a major role in the control of energy availability
[41], and only partially to modulate the inflammatory
response [42]. The basal conditions tested (dietary over-
weight) did not give rise to a marked degree of insulin
resistance [24,43], and the restriction of food intake used
here does not elicit a massive metabolic response that may
put in jeopardy the global energy homeostasis of the ani-
mal. As a consequence, there was not a full activation of
energy stress-related adipokines secretion and/or the
immune response to a severe energy deficit challenge. This
was reflected in less marked gene expression responses of
macrophage attracting factor and interleukins in addition
to TNFα.
The case for VEGF-A and PAI-1 is substantially different:
they act as angiogenic factors [44] and help control the
growth of adipose tissue [45], in spite of having addi-
tional functions such as the modulation of the blood
coagulation path [46]. VEGF-A is highly correlated to tis-
sue weight and (epididymal and mesenteric WAT) to
DNA, but also to glucose, triacylglycerols and the tandem
insulin-leptin. This suggests that VEGF-A may be a fair
indicator of the energy status of WAT. Its direct relation-
ship with NO synthesis [47] and its function as indicator
of endothelial stress [48] point at a probably direct corre-
lation between adipocyte size, growth, and/or energy
availability, direct correlated of NO synthesis [49] possi-
bly being mediated by WAT itself by means of VEGF-A.
Mesenteric WAT stands as fairly different from the other
sites studied, as previously reported [27], because of its
true visceral and mainly processing function. Its smaller
mean cell size reflects in part the large share of non-adi-
pocyte cells it contains [12], as a consequence of its role in
defense-related functions. The close correlations found for
interleukin 1β, the macrophage attracting factor MCP1
[50], and a macrophage marker, CD68 [51] with respect
to DNA agree with this interpretation.
The close relationships between a large proportion of the
adipokine markers studied under two different situations
of WAT energy replenishment with serum parameters: lep-
tin, insulin, triacylglycerols and glucose show that the
response of WAT to changing overall energy homeostasis
is fairly faster than usually assumed. It also shows that,
these serum parameters may be considered as good indi-
cators of the energy status under conditions set within the
physiological range.
Conclusion
The considerable diversity of expression patterns pre-
sented suggest that WAT is far from being an uniform
energy depot, or even behaving as a single dispersed
organ. The main WAT sites studied showed different pat-
terns of regulatory protein gene expression. These data
may be considered indicative of their probable patterns of
secretion if we take as example the case of leptin, in which
we have found a good correlation between serum levels
and the combined WAT specific mRNAs content. In addi-
tion, we have found that there is a certain degree of WAT
site specialization in the differential expression (and
probably secretion) of adipokines (Table 5): subcutane-
ous WAT showed the highest concentration for leptin,
CD68 and MCP-1, mesenteric WAT for TNFα (and both
tissues for the interleukins 1β and 6); resistin was highly
expressed in subcutaneous and retroperitoneal WAT. A
relatively mild energy stress, such as a food restriction
comparable to human hypocaloric diets, induced differ-
ent cytokine expression patterns for mesenteric and the
other WATs; this may be related to both intestine-derived
energy availability and a marked inflammatory-related
response. However, retroperitoneal WAT, and to a lower
extent subcutaneous and epididymal, reacted decreasing
the expression of inflammatory markers and the signaling
of decreased energy availability in their stores.
The data shown highlight the fact that different WAT sites
show different proinflammatory and energy signaling
responses to changes in energy availability, and also that
WAT sites (or their cells) show too many differences to
simply extend to the whole-body WAT the findings
obtained on one or even a couple of sites.
This reflection on the considerable diversity of WAT in the
expression of regulatory adipokines suggests that the
other-smaller, more disperse-WAT sites' role, has to be
analyzed and quantified too before we can establish a glo-
bal role for whole-body WAT.
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